Boryung launches first global CDMO project with Alimta supply

Boryung Corp. said Monday it had begun supplying the anticancer drug Alimta to Lotus Pharmaceuticals, marking its first global contract development and manufacturing organization project. The supply follows a CDMO agreement signed between the two companies in 2024. Boryung said it completed quality verification, regulatory approvals and production preparations at its EU-GMP-certified Yesan Campus before beginning shipments. The company has been expanding its oncology portfolio through acquisitio

By The Korea Herald